王晔院长受邀出席 Juläine发布会，分享抗衰经验，闪耀国际舞台

Core Insights - The collaboration between Saint Boma Group and Nordberg Medical aims to expand the global regenerative aesthetic market, highlighted by the launch of the Juläine PLLA facial filler in the Nordic region [1][2][4] - Saint Boma, a leader in the medical PLLA field, is leveraging its partnership with Nordberg Medical to innovate and apply regenerative material technology, enhancing its presence in the international aesthetic market [2][4] - The launch event attracted over 80 top aesthetic doctors from Sweden, Norway, Finland, and Iceland, showcasing a blend of technology and aesthetics in regenerative solutions [2][4] Group 1: Partnership and Market Position - The partnership between Saint Boma and Nordberg Medical began in 2017, focusing on localized research and production in Europe while adhering to global standards [4] - The successful launch of the Juläine brand in the Nordic region follows previous events in Spain and Italy, marking a significant step for Chinese aesthetic technology in the international market [4] - This strategic alliance exemplifies the combination of "Chinese manufacturing" and "Nordic standards," redefining the competitive landscape of the global regenerative aesthetic market [4] Group 2: Product and Innovation - Aivilan, the first NMPA-certified Class III medical device-grade PLLA facial filler from China, has rapidly become a phenomenon in the aesthetic field since its launch in 2021 [6] - Aivilan has disrupted traditional aesthetic market concepts by introducing the idea of "regenerative materials," leading to a shift in consumer perception from "changing appearance" to "natural self" [6] - The product has established itself as a high-end brand, inspiring other domestic companies to innovate and enhancing China's position in the global aesthetic industry [6] Group 3: Clinical Expertise and Global Influence - The event featured presentations from experts across Europe, with a highlight being Dr. Wang Ye's discussion on the precise application strategies of PLLA in skin anti-aging [8][10] - Dr. Wang's presentation provided valuable clinical insights and demonstrated Aivilan's unique treatment advantages in addressing facial laxity and contour issues, contributing to the global discourse on aesthetic treatments [10][12] - The event marked a significant moment for Chinese aesthetic experts to share clinical experiences with European counterparts, showcasing the potential for cross-regional knowledge exchange [12] Group 4: Future Outlook - Aivilan's emergence is reshaping the global aesthetic landscape, leading to a resurgence of previously marginalized products and a decline in traditional filler market share [14][15] - The company is poised to capitalize on unprecedented opportunities in the aesthetic market, similar to the electric vehicle industry's rapid growth [15] - Aivilan's international expansion will continue, with plans to enter Southeast Asia, South America, the Middle East, Japan, and the U.S., aiming for a comprehensive output of clinical standards and aesthetic philosophies [15]